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We aimed to evaluate the imaging findings of hepatic metastases from pancreatic 
cancers, especially wedge-shaped enhancement and its etiology. 
Dynamic CT and MR images were performed in 87 patients with liver metastases from 
pancreatic carcinomas, and CT during arterial portography (CTAP) and CT during 
hepatic arteriography (CTHA) in 51 patients. 
 Liver metastases were multiple in 84 patients (97%) and solitary in only 3 (3%).  In 44 
of 87 patients (51%), all liver metastases showed ring-like enhancement compatible with 
metastatic adenocarcinomas on dynamic CT and/or dynamic MR imaging. In 37 patients, 
more than one metastatic lesions showed wedge-shaped contrast enhancement on 
dynamic CT, dynamic MRI and CTHA , and wedge-shaped perfusion defect on CTAP 
adjacent to metastatic tumors. Six patients showed multiple wedge-shaped enhancement 
which was initially diagnosed as multiple arterioportal shunts (AP shunts) . However, 
metastatic tumors appeared within the area of wedge-shaped enhancement and increased 
in size on follow-up CT and/or MR images.  After all, 43 of 87 patients (49%) had AP 
shunt like contrast enhancement adjacent to liver metastases. Liver metastases from 
pancreatic carcinomas frequently show transient wedge-shaped enhancement, and should 
not be misdiagnosed as nontumorous arterioportal shunts. 
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Introduction 
The prognosis of invasive pancreatic carcinoma is quite poor, with an overall median 
survival time of 8.6 months and a 5-year survival rate of 9.7 % [1].  Most important factor 
of the prognosis of the patients with pancreatic cancers is liver metastasis. If liver 
metastases were detected by imaging modalities, surgery for pancreatic cancer would not 
be indicated. In Japan during past 20 years, 1459 of 9777 (15%) patients initially showed 
hepatic metastases at the diagnosis of pancreatic carcinoma [1]. Surgery is the only 
curative treatment for pancreatic carcinoma. However, even if curative resection of the 
tumor was performed, most patients have a recurrence including higher rate of liver 
metastases (62%) [2]. High recurrence rate of liver metastases shortly after surgery of 
pancreatic cancer may imply that liver metastases already exist within the liver at the time 
of the operation but are two small to be detected by imaging modalities and intraoperative 
investigation (microscopic metastases) [3].  
CT during arterial portography (CTAP) is considered as a very sensitive imaging 
modality for preoperative work-up of small liver tumors including metastases [3, 4].  
Though CTAP had a high sensitivity of small hepatic lesions, the specificity of CTAP is 
low due to a high rate of false-positive hepatic lesions (pseudolesions) including laminar 
flow, aberrant venous drainage, and arterioportal shunt etc [5, 6].  Angiography 
associated CT such as CT during arterial portography (CTAP) combined with CT during 
hepatic arteriography (CTHA) significant raised the detectability of hepatic tumors and 
an ability of differentiation between hepatic tumors and nontumorous pseudolesions 
[7,8] .    
Metastatic adenocarcinomas from gastrointestinal tumors including pancreatic 
carcinomas usually show ring-like contrast enhancement and delayed contrast 
enhancement of the central portion of the tumors.  We have experienced cases of liver 
metastases secondary to pancreatic carcinomas which showed wedge-shaped contrast 
enhancement adjacent the lesions and occasionally we have encountered unexpected 
cases of liver metastases which have been misdiagnosed as pseudolesions because they 
initially emerged as arterioportal shunts (AP shunts) on dynamic CT, dynamic MR, and 
angiography associated CT (CTAP and CTHA).  So we retrospectively analyzed CT, MRI, 
and angiographic CT findings of liver metastases from pancreatic carcinomas especially 
those of the transient wedge-shaped segmental enhancement associated with metastatic 
lesions. 
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 Materials and Methods 
Patients 
This study was based on 256 patients with pancreatic carcinomas diagnosed 
radiologically and/or pathologically from April 1998 and July 2005 in our institution. In 
87 patients (48 males and 39 females, aged 43 to 85 years, mean 67 years), liver 
metastases were detected by imaging diagnoses (CT, MR, and CT arteriography). 
Contrast enhanced  CT and contrast enhanced MR examinations were performed in all 
patients, whereas abdominal angiography with CT during arterial portography (CTAP) 
and CT during hepatic arteriography (CTHA) in 51 patients.    
 
CT examinations 
CT examinations were performed by helical dynamic CT with a HiSpeed Advantage 
CT scanner or multidetector row CT with a  LightSpeed Ultra 16 (GE Healthcare). 
Precontrast CT and dynamic contrast enhanced CT were done in all patients. Dynamic CT 
was scanned 35 seconds after iodized contrast medium injection (early phase) and 90 
seconds (late phase). The 100-ml of contrast medium was injected at a rate of 3ml/sec 
with a power injector (Nemoto Kyorindo, Tokyo, Japan). CT images were obtained with 
5-mm collimation, pitch of 1.4, and 200 mA for helical CT scanner, and 2.5-mm 
collimation, pitch 1.5 and 200mA for MDCT.  
 
MR examinations  
MR imaging was performed with a superconducting 1.5-T MR imager (Signa 
Horizon; GE Medical Systems, Milwaukee, Wis). Breath-hold in phase and opposed 
phase fast multiplanar spoiled gradient-recalled sequences (FMSPGR; TR 160msec, TE 
4.4 msec [in phase], 2.2 msec [opposed phase], flip angle 90°, one acquisition, 256×128 
matrix), respiratory-triggered fast SE (FSE) T2-weighted images with frequency 
selective fat-suppression technique (TR 3333-6666/ 80-90[effective TR/effective TE], 
echo-train length of 8-12, 256×224 matrix, three acquisitions). The slice thickness was 6 
mm with a 2 mm intersection gap for T1- and T2-wighted images.  Axial dynamic MR 
imaging (FMSPGR, 160/ 1.6/90°, 256×128 matrix, one acquisition, fat suppression) with 
breath holding were performed.  Dynamic MR imaging with FMSPGR sequence was 
acquired before and after intravenous administration of gadopentetate dimeglumine 
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(Magnevist, Schering, Berlin). The Slice thickness was 6mm with 2mm gap.  
 
Angiographic examinations  
 In 51 of 87 patients with hepatic metastases from pancreatic carcinomas, abdominal 
angiography with CT during arterial portography (CTAP) and CT during hepatic 
arteriography (CTHA) was performed for the detection of hepatic metastases. The 
combination of CTAP and CTHA was performed on an Xpeed CT scanner (Toshiba 
Medical, Tokyo, Japan).  CTAP and CTHA were performed after celiac and superior 
mesenteric arteriography. For CTAP, 60ml of iodized contrast material was injected with 
a power injector through the superior mesenteric artery at a rate of 2ml/sec, and CT was 
performed 25 seconds after the start of the injection.  For CTHA, 40ml of contrast 
medium was injected through common hepatic artery at a rate of 1.8 ml/sec and scan was 
stared  10 seconds (early phase) and 60 seconds (late phase) after the start of the injection. 
Scans were obtained with a 5-mm collimation, pitch 1.4 and 200 mA. 
Follow-up dynamic CT of the liver was performed in all patients during a 2-to 
18-month periods (mean 6.3 months). Follow-up dynamic MR imaging was also 
performed in selected cases. In equivocal cases of which tumorous and nontumorous 
transient wedge-shaped contrast enhancement, we diagnosed as liver metastases if 
apparent tumorous lesions appeared within the area of transient wedge-shaped contrast 
enhancement at follow-up CT and/or MR examinations.  
 
Results 
In 87 patients, 84 patients (97%) showed multiple liver metastases and only 3 
patients (3%) revealed solitary liver metastasis.  In 44 of 87 patients (51%), all liver 
metastases showed ring-like contrast enhancement on early phase of dynamic CT (Fig. 1) 
and MR imaging compatible with metastatic adenocarcinomas. Whereas in 37 patients 
more than one metastatic lesion revealed wedge-shaped or fan-shaped transient contrast 
enhancement in the early phase of dynamic CT and dynamic MR imaging adjacent to the 
metastatic liver tumors (Figs. 2-3).  These wedge-shaped area surrounding the metastatic 
lesions showed also wedge-shaped portal perfusion defect on CTAP and wedge-shaped 
contrast enhancement on CTHA. However, six patients showed multiple wedge-shaped 
contrast enhancement on the early phase of dynamic CT, dynamic MR imaging and 
CTHA, and multiple wedge-shaped portal perfusion defects which were initially 
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misdiagnosed as nontumorous arterioportal shunts (AP shunts) (Figs. 4, 5).  However, 
apparent metastatic lesions appeared within the wedge-shaped enhancement and 
increased in size on follow-up CT and/or MR images. After all, 43 of 87 patients (49%) 
had transient wedge-shaped hepatic contrast enhancement mimicking AP shunt adjacent 
to the liver metastases. Only one patient with solitary liver metastases from pancreatic 
head carcinoma associated with wedge-shaped contrast enhancement on dynamic CT and 
wedge-shaped portal perfusion defect on CTAP, underwent hepatic tumor enucleation 
during pancreaticoduodenectomy. Pathologically, metastatic adenocarcinomas 1.5cm in 
diameter showed invasion of the portal tract (Glisson’s capsule) with tumor thrombi 
within the peripheral portal venules (Fig.6).   
 
Discussion 
Several causes of segmental wedge-shaped transient hepatic contrast enhancement 
have been considered, including portal vein compression and thrombosis, arterioportal 
shunt, aberrant venous blood supply, hepatic venous obstruction or thrombosis, hepatic 
abscess, and intrahepatic cholangitis [10, 11, 12]. The segmental transient hepatic 
enhancement associated with liver metastases secondary to pancreatic cancer has not 
been described.  In our cases, 84 of 87 patients (97 %) showed multiple liver metastases 
and 44 of 87 patients (51 %) showed peritumoral rim enhancement compatible with 
adenocarcinoma.  In 43 of 87 patients (49 %), more than one metastatic lesions were 
accompanied by wedge-shaped transient hepatic enhancement on early phase of dynamic 
studies (dynamic CT, dynamic MRI, and CTHA) and wedge-shaped portal perfusion 
defect on CTAP. In 6 patients, we initially misdiagnosed as multiple AP shunts because of 
multiple wedge-shaped contrast enhancement on early phase of dynamic studies and 
portal perfusion defect on CTAP, but follow-up CT showed typical liver metastases with 
in the wedge-shaped contrast enhanced areas.  
The etiology of this transient enhancement related with liver metastases from 
pancreatic cancer is unknown. The reason why liver metastases from pancreatic 
carcinomas have higher frequency of association with AP shunt like wedge-shaped 
enhancement than that of other gastrointestinal carcinomas is also unknown. We 
performed pathological examination of one case of liver metastasis associated with 
wedge-shaped enhancement on dynamic CT and wedge-shaped portal perfusion defect 
on CTAP. Pathologically, liver metastasis 1.5 cm in diameter showed invasion he portal 
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tract with tumor thrombi within the portal venules. We supposed that the etiology of 
transient hepatic enhancement of liver metastasis from pancreatic carcinomas may be 
correlated with the tumor invasion of portal tract and tumor thrombi of portal venules 
which causes decreased portal flow and increased hepatic arterial blood flow.   
The characterizing imaging features of liver metastases including ring like 
enhancement with transient wedge-shaped enhancement should be differentiated from 
liver abscesses [11]. Patients with obstructive jaundice due to pancreatic head carcinomas 
sometimes accompany intrahepatic cholangitis and liver abscesses. Liver abscesses 
frequently show ring-like contrast enhancement with transient segmental contrast 
enhancement on early phase of dynamic CT. The etiology of segmental stain was 
supposed to be that the portal flow decrease and compensatory hepatic arterial flow 
increase due to the stenosis of portal venules within the portal tract surrounding the 
hepatic abscesses [11]. 
Hepatic abscesses sometimes show double target appearance (three layered 
structures: central hypodense area indicating abscess cavity, intermediate rim like 
enhancement indicating abscess wall, and outer hypodense rim indicating secondary 
edema of surrounding hepatic parenchyma) on the early phase of dynamic CT, and thick 
ring-like enhancement of the intermediate and outer layer of them on the late phase [12]. 
Transient segmental contrast enhancement of the hepatic abscesses usually disappear or 
decrease in size on follow-up dynamic CT after the medication of antibiotic agents. These 
double target appearance and serial changes of segmental wedge shaped contrast 
enhancement may a clue to differentiation of hepatic abscesses and hepatic metastases 
secondary to pancreatic carcinoma. 
In our 6 patients, liver metastases initially emerged as wedge–shaped transient 
contrast enhancement without definite ring-like contrast enhancement indicating hepatic 
metastases on CT and MRI, and definite metastatic mass lesions appeared within these 
transient enhanced areas on follow-up dynamic CT.  Differentiation between 
wedge-shaped enhancement of liver metastasis from pancreatic carcinoma and 
nontumorous AP shunt may be difficult. Nontumorous AP shunts are frequently 
associated with liver cirrhosis, wedge-shaped, geographic, and nodular in configuration, 
and sometime show hyperattenuating liner branching structures that represented early 
opacification of portal veins in the early phase of dynamic CT. In our six cases of AP 
shunt like enhancement, early opacification of portal vein branches was not seen. So if 
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portal vein branches were detected within the wedge-shaped enhancement, nontumorous 
AP shunts would be more likely than tumorous perfusion abnormality.  
In patients with pancreatic head carcinoma frequently have obstructive jaundice and 
occasionally suffered from intrahepatic cholangitis.  Intrahepatic cholangitis also shows 
transient inhomogeneous wedge-shaped enhancement on dynamic CT.  The etiology 
transient wedge-shaped enhancement was thought to be  as same as that of  hepatic 
abscess [24]. Transient wedge-shaped hepatic enhancement due to intrahepatic 
cholangitis is also difficult to differentiate from that of hepatic metastases of pancreatic 
carcinomas by imaging diagnoses. However, transient hepatic enhancement due to 
intrahepatic cholangitis and also disappear or decrease in size after treatment of 
cholangitis like hepatic abscesses [12].  So, follow-up dynamic CT or dynamic MRI 
would be encouraged to differentiate between intrahepatic cholangitis and hepatic 
metastasis from pancreatic carcinomas. 
If degree of this wedge-shaped contrast enhancement is slight, we would not 
recognize it itself.  In the case of liver metastases emerging as faint wedge-shaped 
enhancement, angiography associated CT such as CTAP and CTHA depicts hepatic portal 
and arterial perfusion abnormalities more clearly than dynamic CT and MRI. CTAP and 
CTHA may be most effective modalities of surveying liver metastases from pancreatic 
carcinoma, especially emerging as not definite nodular lesions but transient 
wedge-shaped stain on contrast enhanced CT and MRI.  
In conclusion, radiologists should realize that liver metastases from pancreatic 
carcinomas are frequently associated with transient wedge-shaped contrast enhancement 
and occasionally, wedge-shaped enhancement is the only radiological finding of lever 
metastasis, and should not misdiagnose as nontumorous arterioportal shunt.  
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Fig.1—74-year-old woman with pancreatic head carcinoma. Early phase of dynamic CT 
show multiple ring-like contrast enhancement of the liver compatible with metastatic 
adenocarcinoma. 
 
Fig.2—54-year-old man with pancreatic body carcinoma.  
A. On the early phase of dynamic CT,  liver metastases show ring-like enhancement 
associated with transient wedge-shaped contrast enhancement (arrow). 
B. On the late phase of dynamic CT, wedge-shaped enhancement disappeared.  
 
Fig.3—61-year-old woman with pancreatic body carcinoma 
Early phase of dynamic MR imaging shows multiple liver metastases with transient 
wedge-shaped contrast enhancement (arrowhead).  
 
Fig.4—64-year-old man with pancreatic head carcinoma. 
A, B, C.  The early phase (A), late phase (B)  of dynamic CT and T2-weighted MR 
imaging (C) don’t  show any metastatic lesions.  
D, E. CTAP (D) shows multiple wedge-shaped portal perfusion defects and CTHA (E) 
shows wedge-shaped contrast enhancement (arrowhead). Initially, we diagnosed multiple 
AP shunts without liver metastases.  
F. T2-weighted MR imaging performed 2 month later shows small hyperintense 
metastases within the area of wedge-shaped contrast enhancement.  
 
Fig.5—52-year-old man with pancreatic carcinoma. 
A, B. Early phase of dynamic CT shows faint transient wedge-shaped contrast 
enhancement of the liver (arrowhead).  
C, D. Early phase of dynamic MR image shows multiple wedge-shaped contrast 
enhancement of the liver. Delayed phase of dynamic MR and T2-weighted MR images 
(not shown) show no abnormality of the liver parenchyma.  
E, F. CTAP shows multiple wedge-shaped portal perfusion defects (arrow) in concurrence 
with the wedge-shaped enhanced areas of the liver. 
G, H. Contrast enhanced CT obtained 3 months later shows definite multiple liver 
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metastases within the areas of AP shunt like transient contrast enhancement.  
 
Fig.6—74-year-old woman with pancreatic head carcinoma. 
A. Early phase of dynamic CT shows small liver metastasis with surrounding wedge 
shaped contrast enhancement (arrow). 
B. CTAP shows wedge-shaped portal perfusion defect (arrow).  
C, D. Photomicrographs show liver metastasis (M) 1.5cm diameter invading the portal 
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